Impact of response to thalidomide-, lenalidomide- or bortezomib-containing induction therapy on the outcomes of multiple myeloma patients undergoing autologous transplantation

F. T. Awan, S. Osman, S. T. Kochuparambil, L. Gibson, S. C. Remick, J. Abraham, M. Craig, A. Jillella, M. Hamadani

Research output: Contribution to journalLetterpeer-review

4 Scopus citations

Fingerprint Dive into the research topics of 'Impact of response to thalidomide-, lenalidomide- or bortezomib-containing induction therapy on the outcomes of multiple myeloma patients undergoing autologous transplantation'. Together they form a unique fingerprint.